Skip to Content
Menu

Vincent Mase, M.D.

White medical cross on a red shield indicating page is fact-checked by a medical expert Medical Reviewer and Contributor
Photo of Dr. Vincent Mase

Vincent Mase, M.D.

White medical cross on a red shield indicating page is fact-checked by a medical expert Medical Reviewer and Contributor

Dr. Vincent Mase is a board-certified thoracic surgeon who specializes in lung cancer. He serves as a Medical Reviewer for Mesothelioma.com.

He performs minimally invasive surgeries and integrates new technologies to improve patient outcomes. With extensive experience treating lung cancers and other thoracic conditions, he also teaches thoracic surgery at Yale University, mentoring the next generation of surgeons.

His medical journey began at the University of Vermont College of Medicine, followed by a General Surgery Internship at Walter Reed Army Medical Center and a Residency at Fletcher Allen Healthcare. He later completed a Cardiothoracic Fellowship at Brigham and Women’s Hospital, earning recognition from the Accreditation Council for Graduate Medical Education.

Beyond his medical career, Dr. Mase has dedicated 20 years to military service, including extensive time overseas. As a decorated officer, he continues to serve as a Lieutenant Colonel in the U.S. Army Reserves and remains committed to caring for military personnel and veterans.

“For many of my patients, this is their first experience with a life-threatening illness and their first experience navigating through a hospital system.”

Recognizing the importance of patient education, he ensures individuals and their families fully understand their treatment options—both surgical and nonsurgical. One of the most rewarding aspects of his work, he says, is “seeing them outside of the office—maybe at the mall—and they are doing well, getting back to their lives.”

His expertise extends beyond the operating room, with numerous publications in medical journals covering lung cancer, surgical techniques and advancements in thoracic surgery.

Selected Publications

So now we know-reflections on the extent of resection for stage i lung cancer. Clin Lung Cancer. 2024 May;25(3):e113–23.

Overall survival in low-comorbidity patients with stage I non-small cell lung cancer who chose stereotactic body radiotherapy compared to surgery. J Thorac Cardiovasc Surg. 2024 Mar;167(3):822-833.e7.

Surgical management of pneumothorax and pleural space disease. Surg Clin North Am. 2022 Jun;102(3):413–27.